45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
2,092
Insurances with rates
5
CPT / HCPCS codes
2,054
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2350 | Ocrelizumab Injection 300 mg | $78,799 | $32,938 | — | — | 4 |
| J9119 | Cemiplimab-rwlc Inj 350mg | $43,271 | $18,088 | — | — | 5 |
| J9022 | Atezolizumab Inj 1200 mg | $42,956 | $17,956 | — | — | 4 |
| J9144 | Daratumumab/Hya 1800-30000 | $40,159 | $16,787 | — | — | 4 |
| J3380 | Vedolizumab Inj | $38,591 | $16,132 | — | — | 4 |
| J9228 | Ipilimumab Injection | $34,568 | $14,450 | — | — | 4 |
| J9301 | Obinutuzumab Inj | $34,361 | $14,364 | — | — | 4 |
| J9223 | Lurbinectedin Inj 4 MG | $31,019 | $12,966 | — | — | 4 |
| J3101 | Tnkase | $30,011 | $12,545 | — | — | 4 |
| J9306 | Pertuzumab Inj | $26,040 | $10,885 | — | — | 4 |
| J2353 | Sandostatin Lar Depot 30mg | $24,818 | $10,374 | — | — | 4 |
| J9332 | Efgartigimod alfa-fcab 400mg | $24,113 | $10,080 | — | — | 5 |
| J9271 | Pembrolizumab Inj | $22,969 | $9,601 | — | — | 4 |
| J2506 | Pegfilgrast Delivery Kit 6M | $16,811 | $7,028 | — | — | 4 |
| J9173 | Durvalumab Inj 500 mg | $16,399 | $6,855 | — | — | 4 |
| J9177 | Enfortumab Vedotin-Ejfv 30 mg | $16,088 | $6,725 | — | — | 5 |
| J9354 | Ado-Trastuzumab Emtansine Inj | $15,008 | $6,274 | — | — | 4 |
| 15273 | Skin Sub Grft T/Arm/Lg Child | $14,221 | $5,945 | — | — | 5 |
| J0896 | Luspatercept - AAMT 25 MG | $13,943 | $5,829 | — | — | 5 |
| J2182 | Mepolizumab 100mg Inj | $13,673 | $5,716 | — | — | 4 |
| J0897 | Denosumab 120 mg | $12,510 | $5,230 | — | — | 4 |
| J9358 | Fam-Trastu Deru-Nxki Inj 100MG | $12,375 | $5,173 | — | — | 5 |
| 81408 | Mopath Procedure Level 9 | $12,231 | $5,113 | — | — | 5 |
| Q5111 | Udenyca Pegfilgrastim-cbqv 6mg | $11,813 | $4,938 | — | — | 5 |
| 10180 | I&D Cplx Postop Wnd Inf | $10,924 | $4,567 | — | — | 5 |
| 81442 | Noonan Spectrum Disorders | $10,726 | $4,484 | — | — | 5 |
| 81443 | Genetic Tstg Severe Inh Cond | $10,401 | $4,348 | — | — | 5 |
| J3111 | Romosozumab-Aqqg 210 mg | $10,035 | $4,195 | — | — | 5 |
| L8641 | Toe Joint Implant | $9,922 | $4,148 | — | — | 5 |
| Q4104 | Bioengin Skin Sub or Dressing | $9,848 | $4,117 | — | — | 4 |
| J9317 | Sacituzumab Govitecan-hziy 180 | $9,596 | $4,012 | — | — | 4 |
| J9205 | Irinotecan Liposome | $9,437 | $3,945 | — | — | 4 |
| E0747 | Electromag Therapy Stimulator | $8,750 | $3,658 | — | — | 4 |
| J9176 | Elotuzumab 300 mg | $8,351 | $3,491 | — | — | 4 |
| 70549 | MRA Angio Neck w/wo Dy | $8,324 | $3,480 | — | — | 5 |
| 70546 | MRA Angio Head w/wo Dye | $8,283 | $3,463 | — | — | 5 |
| 81162 | BRCA 1&2 Gen Full Seq Dup/Del | $8,119 | $3,394 | — | — | 5 |
| 64635 | FL RFA Spine MBB L-S w/Imaging | $7,939 | $3,319 | — | — | 5 |
| 71552 | MRI Chest w/wo Dye | $7,568 | $3,164 | — | — | 5 |
| Q5122 | Pegfilgrastim-apgf 6 mg | $7,436 | $3,109 | — | — | 4 |
| 77049 | MRI Breast w/wo Con w/CAD Bil | $7,383 | $3,087 | — | — | 5 |
| C8908 | MRI Breast w/o Fol w/cont | $7,383 | $3,087 | — | — | 5 |
| J1602 | Golimumab IV 50mg/4ml | $7,253 | $3,032 | — | — | 4 |
| J3032 | Eptinezumab-Jjmr 100mg/1ml Via | $7,208 | $3,013 | — | — | 5 |
| 15274 | Skn Sub Grft T/A/L Child Add | $7,111 | $2,973 | — | — | 5 |
| 95811 | CPAP Titration, Fully Attended | $7,072 | $2,957 | — | — | 5 |
| 35226 | Rpr Blood Vessel Lower Ext | $7,072 | $2,957 | — | — | 4 |
| 173 | Critical/Intnsive Care Nursery | $6,978 | $2,917 | — | — | 3 |
| Q5108 | Pegfilgrastim-Jmdb 6 mg | $6,529 | $2,730 | — | — | 5 |
| 11044 | Deb Bone 20 Sq cm or Less | $6,487 | $2,712 | — | — | 5 |
Showing top 50 of 2,092 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.